Hansa Biopharma AB (Nasdaq Stockholm: HNSA), a pioneer in treatments for rare IgG related immunologic conditions, today ...
Research and Markets has opened registration for the live online course, Protein Engineering for Pharmaceutical Biotechnology, organized by IPI Academy and taking place February 2-3, 2027, equipping ...
BRISTOL, TN / ACCESS Newswire / October 7, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) is quietly redrawing the boundaries of what a biotechnology company can be. The company has ...
Pharmaceutical engineering is a powerful career pathway for students who want to turn scientific knowledge into medicines that make a real difference to patients’ lives. An MSc in Pharmaceutical ...
The ability of scientists to rationally engineer organisms using synthetic biology, or “engineering biology” as I prefer to call it, has progressed greatly since high throughput molecular biology ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be Biopharma, Inc. (“Be Bio”), a company pioneering the discovery and development of Engineered B Cell Medicines (BeCMs), will present preclinical research today ...
NXC-201 (formerly HBI0101) is a BCMA-targeted investigational chimeric antigen receptor T (CAR-T) cell therapy that is being studied in a comprehensive clinical development program for the treatment ...
In biopharma research and development, laboratory data now exist in petabytes. Today’s fastest liquid-handling robots can dispense samples into 384 wells in a matter of seconds. Vaccines, which have ...
Successful completion supports expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial to the U.S. NXC-201 is manufactured at our state-of-the-art cellular immunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results